To determine whether endothelin-1 (ET-1) induces hypertrophy of cardiomyocytes, the effects of ET-1 on the expression of muscle-specific genes and a proto-oncogene, c-fos, in cultured neonatal rat cardiomyocytes were examined by Northern blot analysis. ET-1 (10-`M) induced about twofold to fourfold increases in the gene expression of myosin light chain 2, a-actin, and troponin I after 6 hours, which continued up to 24 hours. The ET-1-induced increases in mRNA levels for these muscle-specific genes were dose dependent (10-9 to 10`M). Run-on transcriptional assay showed that the changes in mRNA level for three muscle-specific genes were regulated, at least in part, at the transcriptional level. 12-O-Tetradecanoylphorbol 13-acetate (TPA), a potent protein kinase C activator, and the Ca2' ionophore ionomycin also increased mRNA levels of three muscle-specific genes. ET-1, TPA, and ionomycin similarly induced the expression of c-fos after 30 minutes, which returned to an undetectable level after 6 hours. ET-1 remarkably and dose-dependently stimulated accumulation of total inositol phosphates in cardiomyocytes. Morphometrical evaluation showed that ET-1 significantly increased surface area of cardiomyocytes without cell proliferation. ET-1 also dose-dependently stimulated the synthesis of protein and DNA, which was unaffected by the L-type calcium channel blocker nicardipine. These data suggest that ET-1 induces hypertrophy of cardiomyocytes associated with the induction of muscle-specific gene transcripts through the In the present study, we demonstrated that ET-1 induces hypertrophy with concomitant increases in the transcripts of muscle-specific genes and a proto-oncogene, c-fos, as well as augments DNA and protein synthesis in cultured neonatal rat cardiomyocytes.
mRNA level in cultured neonatal rat cardiomyocytes. 4 However, the pathophysiological role of ET-1 in cardiomyocytes, especially its possible involvement in cardiac hypertrophy, remains open to question.
In the present study, we demonstrated that ET-1 induces hypertrophy with concomitant increases in the transcripts of muscle-specific genes and a proto-oncogene, c-fos, as well as augments DNA and protein synthesis in cultured neonatal rat cardiomyocytes.
Materials and Methods Drugs and cDNAs
The following drugs were used: synthetic endothelin-1 (Peptide Institute, Osaka, Japan); 12-0-tetradecanoylphorbol 13- (Amersham Japan, Tokyo) . cDNAs for three muscle-specific genes used for probes were generously provided by Dr. L. Kedes (University of Southern California, Los Angeles): a-actin,5 troponin 1,6 and myosin light chain 2 (MLC2).6 cDNA for glyceraldehyde-3 -phosphate dehydrogenase (GAPDH)7 was a kind gift from Dr. K. Webster (SRI International, Menlo Park, Calif.). cDNA for c-fos was from the Japanese Cancer Research Resources Bank, Tokyo.
Cell Culture
Primary culture of neonatal rat cardiomyocytes was prepared by the method originally described by Simpson and Savion8 with minor modifications. 6 Briefly, the hearts from 1-or 2-day-old Wistar. rats (Japan Laboratory Animals, Tokyo) were minced and dissociated with 0.1% trypsin. After dispersed cells were incubated on 100-mm culture dishes (Falcon, Oxnard, Calif.) for 60 minutes at 37°C in 5% C02, nonattached viable cells were collected and seeded into 60-mm dishes (2x106 cells/dish) or The effects of ET-1 on muscle-specific and c-fos gene expression in cultured neonatal rat cardiomyocytes as evaluated by Northern blot analysis are shown in Figure 1 . ET-1 (10`M) increased gene expression of MLC2 (2.6-fold), a-actin (1.6-fold), and troponin I (3.6-fold) after 6 hours, which continued up to 24 hours. In contrast, ET-1 transiently induced the expression of c-fos after 30 minutes, which returned to an undetectable level after 6 hours. TPA (10`' M) also increased the mRNA level of three muscle-specific genes after 6 hours, which persisted up to 24 hours. The mRNA level of each muscle-specific gene was similarly induced by ionomycin (10`M) and returned to the control level after 24 hours. Both TPA and ionomycin transiently induced the expression of c-fos at 30 minutes ( Figure 1 ).
As shown in Figure 2 , ET-1 dose-dependently (10t o 10`9 M) stimulated accumulations of mRNA for MLC2, a-actin, and troponin I in rat cardiomyocytes after 24 hours, whereas ET-1 did not affect mRNA levels for GAPDH, which was used as the control.
Run-on Transcription Analysis
Run-on transcriptional assay revealed that 10`' M ET-1 stimulated increases in transcription of MLC2, a-actin, and troponin I, but not of GAPDH ( Figure  3) ; ET-1 significantly (p<0.01) increased transcriptional activities of MLC2 by approximately 1.9-fold, a-actin by 1.2-fold, and troponin I by 1.9-fold over control, whereas ET-1 had no effect on GAPDH transcriptional activity. Figure  1 ). 
Discussion
The present study demonstrates for the first time that ET-1, a novel endothelium-derived vasoconstrictor peptide, has a hypertrophic effect on rat cardiomyocytes associated with increases in the transcripts of muscle-specific genes (MLC2, a-actin, and troponin I) and the c-fos proto-oncogene. 23 suggesting that the growth of cardiomyocytes is mediated by PKC. On the other hand, ET-1 also stimulates phospholipase C-mediated breakdown of phosphoinositide24 and an increase in cytosolic free Ca21 levels resulting from Ca21 influx and mobilization25 in vascular smooth muscle cells. Recent studies have also shown that ET-1 induces Ca21 influx as well as intracellular Ca21 mobilization resulting from inositol 1,4,5-trisphosphate generation in rat atrial cells. 26 In the present study, ET-1 stimulated the transcripts of three muscle-specific genes and c-fos in the rat cardiac cells, all of which were similarly activated by PKC activating TPA and the Ca21 ionophore ionomycin. In addition, the present study revealed that ET-1 remarkably increased the accumulation of total inositol phosphates in rat cardiomyocytes with concomitant induction of three muscle-specific genes and c-fos gene expressions. Taken together, these data led us to speculate that the activation of PKC or Ca21 mobilization resulting from receptor-mediated phosphoinositide breakdown might be involved in the mechanism of the ET-1-induced hypertrophy of cardiomyocytes.
Whether PKC or intracellular Ca2' mediates the mechanism of hypertrophy of cardiomyocytes by ET-1 needs to be elucidated.
The failure of nicardipine to affect ET-1-induced protein and DNA synthesis suggests that Ca2' influx through voltage-dependent L-type Ca21 channels does not play any important role in the mechanism of the ET-1-induced hypertrophy of cardiomyocytes. This is compatible with the data by Vigne and coworkers,26 in which the inotropic action by ET-1 can develop in the presence of L-type Ca21 channel blockers and the ET-1-induced Ca21 influx comes from the Ca2' entry via a pathway that is not voltagedependent L-type Ca2' channels.
